Enhancing the experience of carers in the chemotherapy outpatient setting:an exploratory randomised controlled trial to test impact, acceptability and feasibility of a complex intervention co-designed by carers and staff by Tsianakas, V. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1007/s00520-015-2677-x
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Tsianakas, V., Robert, G., Richardson, A., Verity, R., Oakley, C., Murrells, T., ... Ream, E. (2015). Enhancing the
experience of carers in the chemotherapy outpatient setting: an exploratory randomised controlled trial to test
impact, acceptability and feasibility of a complex intervention co-designed by carers and staff. Supportive Care in
Cancer, 23(10), 3069-3080. 10.1007/s00520-015-2677-x
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
Offering antenatal sickle cell and thalassaemia
screening to pregnant women in primary care:
a qualitative study of womens experiences and
expectations of participation
Vicki Tsianakas BHSc Hons DPhil,* Karl Atkin BA Hons DPhil, Michael W. Calnan MSc PhD,
Elizabeth Dormandy MSc PhD§ and Theresa M. Marteau PhD–
*Research Fellow, School of Nursing, Kings College London, London, UK, Professor of Ethnicity and Health, Department of
Health Sciences, University of York, York, UK, Professor of Medical Sociology, School of Social Policy, Sociology and Social
Research, University of Kent, Canterbury, UK, §Research Fellow, Division of Health and Social Care Research, Kings College
London, London and –Professor of Health Psychology, Institute of Psychiatry, Kings College London, London, UK
Correspondence
T. M. Marteau, PhD
Professor of Health Psychology
Kings College London, Guys Campus
5th Floor Bermondsey Wing
London SE1 9RT
UK
E-mail: theresa.marteau@kcl.ac.uk
Accepted for publication
7 January 2011
Keywords: ethnic groups, genetic
screening, sickle cell, thalassaemia
Abstract
Objective To describe the acceptability to women of being oﬀered
antenatal Sickle cell and Thalassaemia (SC&T) screening in primary
and secondary care at the visit to conﬁrm pregnancy; and to explore
the implications of their views for participating in decisions about
their health care.
Methods Qualitative semi-structured interviewswereconductedwith
twenty-one ethnically diverse women registered at twenty-ﬁve general
practices in two English inner-city Primary Care Trusts. The material
was analysed thematically, using the method of constant comparison.
Results Women generally welcomed the opportunity of early diag-
nosis, although they expected screening to conﬁrm they were
carrying a healthy child. Women felt general practitioners did not
present antenatal screening as a choice, but they did not necessarily
see this as a problem. Doctors were believed to be acting out of
concern for the womens well being.
Conclusions Women were generally positive about being oﬀered
screening in primary care at the ﬁrst visit to conﬁrm pregnancy. To
this extent it was acceptable to them, although this was largely
informed by assumptions associated with being a good mother
rather than a straightforward enactment of informed choice,
assumed by health-care policy. This represents the context in which
women participate in decisions about their health care.
Introduction
An antenatal sickle cell and thalassaemia
(SC&T) program is currently being implemented
in the UK, with the aim of oﬀering timely
antenatal screening to all women to facilitate
participative informed decision making.1 Timely
informed decision making is an explicit objec-
tive. Accompanying guidelines propose that
antenatal SC&T screening, including pre-natal
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diagnosis, should be completed by the twelfth
week of pregnancy.2,3 To achieve this, screening
should be oﬀered by 10 weeks gestation.1 When
oﬀered during the ﬁrst trimester, pre-natal
diagnosis seems highly acceptable, irrespective
of ethnic origin.4,5 Screening too late in preg-
nancy, however, may mean that women are
reluctant to undergo invasive pre-natal testing.6
This assumes particular resonance for UK pol-
icy, as most women are not screened until
15 weeks gestation,7 many weeks after ﬁrst
reporting their pregnancies to their GPs. These
problems, however, are not peculiar to the UK.
Access and acceptability of screening
The aim of this article is to explore womens
acceptability of, and preferences expressed dur-
ing, antenatal SC&T screening within a multi-
cultural context. We were especially interested in
the extent to which women think they partici-
pate in informed decision making about
screening. We acknowledge that when women
exercise preferences with regard to SC&T
screening, they bring with them a set of values
and assumptions as well as cultural resources
which will inﬂuence their perceptions and expe-
riences.8 This is the context in which policy is
enacted and one of the problems associated with
antenatal screening is the failure to contextualise
womens perceptions and experiences. In this
article, acceptability of screening and womens
expression of autonomy is explored in relation
to this broader context rather than seen as
rational choice made on the basis of information
provided by health-care professionals.
There are generally high levels of acceptability
of screening among women, who express feelings
of maternal responsibility for the unborn child.9
In the context of SC&T, mothers (and fathers)
prefer screening as early as possible and in many
cases, pre-conceptually.5 Normative ideas of
what makes a good mother have been used to
explain womens enthusiasm for screening,
especially when test results conﬁrm there is no
risk to the unborn child.10 Other more speciﬁc
factors also come to mediate womens responses.
A womans prior knowledge of SC or T, for
example, is likely to inﬂuence her preferences
related to the screening process.11 This can be
seen among African-Caribbean women who,
because of their history, tend to have a stronger
cultural repertoire in which to make sense of SC
when compared with South Asian women and
thalassaemia.12 Increased knowledge can help
facilitate timely informed choices. Several stud-
ies, however, have highlighted how those from
minority ethnic groups tend to be less aware of
services or conditions aﬀecting them, when
compared with majority populations. Women
who know nothing about thalassaemia are likely
to experience diﬃculty in exercising choice, if the
ﬁrst time that they have heard about the condi-
tion is during the early stages of their pregnan-
cies. When ethnic minority populations do
access services, they may also be more likely to
experience inappropriate provision, due to cul-
tural insensitivity and institutional racism, which
further undermine the acceptability of screening
and the exercise of choice.13–15 Preferences for
pre-natal diagnosis (and termination) are
incredibly sensitive to individual and cultural
context; and many practitioners struggle to
engage with this.12
Acceptability is mediated by health-care pro-
fessionals and the broader institutional contexts
in which they work. Health professionals are
responsible for delivering information and
increasing awareness about available procedures
and can therefore inﬂuence screening and pre-
natal diagnosis uptake and decisions about ter-
mination of aﬀected pregnancies.16,17 Evidence
from the ﬁrst part of this study suggests that
GPs believe patients trust in them would help
facilitate oﬀering screening to women in primary
care.18
Methods
Qualitative in depth interviewing was chosen as
the most applicable technique for a study that
sought contextualised personal accounts of
SC&T screening. This qualitative account was
embedded in the Screening for Haemoglobino-
pathies in the First Trimester Trial, which aimed
to assess the feasibility, acceptability and
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eﬀectiveness of oﬀering antenatal screening for
SC&T in primary care.19 Ethical approval was
granted for the whole study (05 ⁄Q0501 ⁄36). The
trial took place in two UK inner city Primary
Care Trusts (PCTs). The two PCTs ranked
among the most deprived in England (sixth and
13th out of 354 boroughs) and 40% of their total
populations are from minority ethnic groups.17
Antenatal SC&T screening was oﬀered to all
pregnant women regardless of their ethnicity or
family origin. Those eligible to take part in the
trial were: pregnant women attending partici-
pating practices, who wanted to continue the
pregnancies, were <20 weeks (19 weeks and
6 days) gestation at their ﬁrst visit to primary
care; and had no written record of their SC and
T carrier status.17
Our qualitative sample was generated from
this larger trial sample. A purposeful sample of
women was gathered, with the aim of recruiting
women who varied in ethnic origin, country of
birth and carrier status (see Table 1). The spe-
ciﬁc aim was not to essentialize ethnicity by
exploring it in isolation from other aspects of a
womans experience. GPs asked all eligible
women if their contact details could be passed
to the research team so that information about
the trial could be provided. Women were also
asked if they would be willing to talk more
about their experience. For those willing to
take part, a researcher contacted women by
telephone to seek formal consent for their
participation in the qualitative study. Inter-
views were then set up. It is diﬃcult to know a
great deal about the types of people who do
not take part in research. Diversity in the
background and experience of our sample
suggest we engaged with a broad range
of women, although those from lower socio-
economic groupings were probably less likely to
have been interviewed.
Women were recruited from all three arms of
the trial which were: Group 1: screening at
pregnancy conﬁrmation visit in primary care,
with parallel father testing; Group 2: screening
at pregnancy conﬁrmation visit in primary care,
with sequential father testing; and Group 3:
midwife-led care, with sequential father testing.
Of the women taking part in the qualitative part
of the study, 16 were oﬀered screening in
Table 1 Womens demographic data
Participant Trial arm Age Ethnicity* Born in UK Couple type Carrier status
P1 2 27 Black African No Same – minority Carrier
P2 1 32 Black Caribbean Yes Not known Carrier
P3 2 26 White European No Same – white Not carrier
P4 2 25 South Asian No Same – minority Not carrier
P5 2 31 Black Carribean Yes Same – minority Not carrier
P6 2 26 South Asian Yes Same – minority Carrier
P7 2 28 South Asian No Same – minority Not Carrier
P8 1 31 Black Caribbean No Same – minority Carrier
P9 2 25 White Yes Not known Not carrier
P10 2 29 Black African No Same – minority Not carrier
P11 1 32 White Yes Same – white Not tested
P12 2 31 South Asian No Same – minority Carrier
P13 1 29 Black African No Same – minority Carrier
P14 1 28 White No Same – white Not carrier
P15 3 30 White Yes Same – white Not carrier
P16 3 30 White Yes Same – white Not carrier
P17 2 26 Chinese No Mixed minority Not tested
P18 3 28 White Yes Same – white Not carrier
P19 3 32 Black Caribbean Yes Not known Not tested
P20 3 31 White Yes Same – white Not carrier
P21 1 28 Black Caribbean No Same – minority Carrier
*Patients self selected.
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primary care and ﬁve were oﬀered screening by a
midwife in secondary care.
Seventeen interviews were conducted in
English and four in Spanish, French or Somali.
Although not perceived as good practice in
qualitative research an interpreter was employed
for these four interviews because no one in the
research team spoke these languages. Women
were given a choice of where they preferred the
interview to take place. Nineteen women were
interviewed in their homes and two at their GP
practices.
All interviews were carried out or supervised
by an experienced researcher. Each interview
lasted approximately 45–60 min. Women
received a £10 gift voucher for their time (and
were informed of this prior to the interview).
The interviewers used a topic guide, which was
developed during the pilot phase of the study
and modiﬁed as data collection took place. The
topic guide began with the general themes
about the oﬀer of screening, including womens
prior knowledge of SC&T; the timing of the
test; and how the test was oﬀered. It then
focused on the womans decisions about
accepting or declining screening and where
relevant, her experience with receiving results.
Finally, women were asked to reﬂect on the
screening process.
Our eventual sample included 21 women, with
an average age of 29 years, eight of whom
described themselves as white, three black
African, ﬁve black Caribbean, four south
Asian and one chinese origin (See Table 1).
The sample was perceived to give suﬃcient
diversity, reﬂecting the nature of a multi-cultural
population and the diﬀerent possible screening
decisions and outcomes.
Informal interpretation began during the
interview process because data collection and
analysis were set up as an iterative process. This
enabled the research team to clarify and further
probe emerging issues. The team began formal
analysis of the interview data after the tran-
scription process was completed. Practically,
transcripts were organized using NVivo software
package.20 The material was analysed themati-
cally across all groups using the method of
constant comparison in which common themes
and ideas were identiﬁed as the basis of
abstracting the meaning. Themes were interro-
gated within the context of each individual
account, as means of understanding a particular
case, compared across cases by highlighting
potential similarities and diﬀerences and ﬁnally,
related to those characteristics of the informant
that could reasonably be justiﬁed as an expla-
nation which mediated experience.
The research team conducted all interviews
and discussed transcripts, to ensure quality and
shared understanding of the signiﬁcant issues.
Five interviews were double coded by two of
the authors. No substantial diﬀerences in
interpretation occurred. There was, however,
considerable discussion of how certain themes
could be interpreted. This strengthened the
analytical process and ensured that the
research team could explore possible, alterna-
tive interpretations. Other speciﬁc issues, how-
ever, need to be considered when interpreting
the material, particularly since design and
methodology always limit the potential trans-
ferability of the ﬁndings. Although our sample
is culturally diverse, the small size limits our
conclusions about social class diﬀerences,
which might be an important mediator of
womens experience. The research was also
carried out in urban localities with large ethnic
minority population. Perhaps more impor-
tantly, our sample included women who
by-and-large were told they were not at risk.
This might explain the generally positive
response of our sample to screening and our
discussion reﬂects on the implications of this.
At the same time, however, we feel that our
work provides a valuable thematic account
reﬂecting the experience of women, faced with
ante-natal screening for SC and T disorders.
Findings
In making sense of womens perceived partici-
pation in decisions about screening at the time of
their pregnancy conﬁrmation, three themes were
identiﬁed: the perception of the beneﬁts of
early screening; satisfaction and expectations of
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participation and involvement in decision mak-
ing when oﬀering screening; and the need for
information.
The perceived beneﬁts of early screening
Consistent with other studies, when asked about
the most appropriate time to be oﬀered SC&T
screening, all women felt it should be oﬀered as
early as possible believing early diagnosis would
provide them with more options when making
decisions about their pregnancies. Women usu-
ally justiﬁed this by focusing on the danger of
late diagnosis. One woman said:
Its important to have it done especially at an early
stage…it could be very dangerous leaving it too
late. Its best to know whats happening. If you are
a carrier you can be treated….(P5).
The use of the phrase treated is interesting in
this context, illustrating a potential confusion
between the boundaries of health and illness,
ascribed to testing for genetic conditions. This as
we shall see, is an underlying theme. Women
speciﬁcally talked about the diﬃculty of termi-
nation in advanced stages of pregnancy, partic-
ularly when the mother has already started to
bond with her unborn baby. One woman
argued that terminating a pregnancy would be
far easier at 6 weeks, rather than later:
At 19 weeks Im already showing! If you know
from earlier on that your child will suﬀer from
sickle cell, you can make that choice to terminate
but so late in the pregnancy? You have bonded
with your child already…you just want to continue
with it [the pregnancy] (P2).
Women, therefore, preferred to be oﬀered
screening early by their GPs rather than at a
later stage by a midwife. They believed it
important to know their status from the outset,
giving them more time to work through their
options. One woman speciﬁcally reﬂected on her
own stressful experience of being diagnosed as a
carrier of SC at an advanced stage of her preg-
nancy:
I think we should have screening the ﬁrst time we
see the doctor. I was screened at the end of my
third or fourth month of pregnancy and the results
said I was a carrier. They called my husband and
by then I was almost 4 months pregnant. I was
worried that if my husband had the trait I might
have to go for an abortion… at four, 5 months
[gestation] its very hard for anyone (P12).
Wanting a healthy baby explained the
womens advocacy for early screening and most
emphasised the importance of obtaining their
and their partners carrier status as early as
possible. One woman stated:
I want a healthy baby so in the early stages of
pregnancy I would take any decision that will be
safe for my child (P4).
Many women spoke of the importance of
being prepared, either to continue with their
pregnancies or for termination, and expressed
the view that early diagnosis allowed for this.
One woman remarked (while also reﬂecting a
further blurring of the boundaries between
health and illness):
Its better to have it done earlier because youre just
prepared for it. If you do have a disorder you are
aware of it (P7).
Some women said SC&T screening should be
done pre-conceptually in order for parents to be
aware of their status before conceiving:
I think if you do the blood test before [pre-con-
ceptually] and ﬁnd out that youre carrying a dis-
ease you wont get pregnant but if youre already
pregnant and then you ﬁnd out you have a con-
dition, I think its quite stressful (P3).
Women generally expressed such views in the
context of responsible motherhood. A good
mother would do all she could to facilitate a
healthy pregnancy. Many of the women in our
sample uncritically accepted this.
Nonetheless, in agreeing to be tested most
women expected conﬁrmation that they were
carrying a healthy child. This is an important
consideration when interpreting the above
comments. Womens enthusiasm for screening
was based on an assumption that all would be
well and in doing so, were trying to make sense
of a broader policy tension between prevention
and early detection. Their commitment to
screening was underpinned by a strong
assumption that all would be well and that their
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child would be healthy. This informs their more
general expectations of participating in informed
decision-making processes.
Satisfaction and expectations of being involved
in decision making
Many women felt that GPs oﬀered screening in a
way that facilitated choice. They spoke about
being given the time to think about whether they
wanted to be screened, as this woman expressed:
The doctor told me, you make up your mind
about whether you want to do the test or not. If
you dont want it, its okay. So he actually gave me
time. After a week I went back in and made an
appointment (P10).
At the same time, women also spoke about
how their GPs encouraged them to undertake
screening, presenting it in a positive light. One
remarked:
The doctor didnt go into detail…she said its
better to have the test done because Asian women
were more prone to this disorder (P6).
Some women spoke about not being given a
choice by their GPs, but did not necessarily see
this as a problem:
I dont think the doctor gave a choice. The doctor
said go tomorrow for this test. Im happy because
its beneﬁcial for us. Thats why hes saying that
(P12).
Several women speciﬁcally implied that doctor
knew best. Women spoke about trusting their
GPs as they believed he or she would recommend
whatever was in the womens best interests.
Consequently, they did not really expect to par-
ticipate in decision making about screening:
You had a choice but why give a choice? If the
doctor recommends it, you should do it. (P10).
Another woman agreed:
I was given a choice whether I wanted to have it
done or not. She told me it was better to have it
done. I did it because she told me to do it and I
trust her (P6).
Further, many women, irrespective of eth-
nicity, believed their GP had more authority
than a midwife to oﬀer screening. This con-
ﬁrmed their trust in doctors, which might not
necessarily be conferred on other health-care
professionals.
Womens expectations of the consultation
process and the trust they had in doctors, meant
their GP could exercise considerable inﬂuence,
but another woman did not see this as a prob-
lem, simply a natural extension of the doctors
role, which was not questioned. When women
were asked why they agreed to screening, they
often responded that it was because it was pre-
scribed by the GP: The doctor suggested it and
I just followed their advice.
Interestingly the few women who had been
oﬀered screening in secondary care by their
midwives were less aware of being oﬀered SC&T
screening, largely because it became lost, part
of a broader package of screening tests:
I cant recall a very serious or speciﬁc conversation
about sickle cell. Maybe it was contained in a wider
range of tests and Ive not picked up on it (P20).
So despite their low expectations of choice,
women felt more involved in decision making
when screened in primary care, than they did in
secondary care.
The need for information
Despite their low expectations of choice, many
women felt GPs did not spend enough time
explaining the conditions for which screening was
beingoﬀered.Consequently, they felt ill informed:
Its just nice when you go to your doctor for the
ﬁrst time to have a little bit of information about
whats going to be happening to you and the things
that you have to go through (P7).
At the initial consultations with their GPs,
women were given a leaﬂet about SC and T to
take home and read. However, a number of
women explained that in addition to that, GPs
should have spent more time explaining the
conditions face-to-face:
When they explain the test to you and then you
read about it you get a clearer understanding of it
rather than just reading the leaﬂet on your own.
Then you can make up your mind (P5).
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Those women who had been diagnosed as
carriers of SC were especially unclear about
what this meant: I wouldnt mind knowing
more. As a carrier I still dont know what it is.
Another said:
I just found out that I was a carrier so I really want
to know more about it, whether its going to aﬀect
my baby or not, thats what Im really concerned
about. The doctor didnt give me that information
(P8).
This seems to raise a potential contradiction
in the womens accounts. They trust their GP,
while criticising them for not providing enough
information. For some women, anxiety explains
their response; they want as much reassurance as
possible in ensuring they are carrying a healthy
child. On the other hand, for those conﬁrmed as
carriers of the condition the context has now
changed. They are faced with making a decision
they did not expect to have to make. This further
suggests that their trust in GPs and broader
acceptability and satisfaction with the screening
process, depends on women assuming nothing is
wrong.
This would change if a problem was identiﬁed
and suggests their acceptability of screening is
contingent. Womens passivity can transform in
to more proactive engagement. Women identi-
ﬁed at risk, for example, tended to re-evaluate
their previous acceptance and retrospectively
adapted a more critical approach to participa-
tion in the decision-making process, feeling their
GP should have involved them more. This is
consistent with the idea of being a good mother.
Finally, several women who did not have
English as a ﬁrst language felt especially disad-
vantaged by the screening process oﬀered by
their GPs: a recurring theme in the policy liter-
ature:
I would like to know more about whether it is a
serious matter because I dont understand very
well English. I didnt really know what was going
on. It was a surprise when they told me I had the
condition because I never heard about it and I
would have liked to know more about it. They
cant explain to me everything, I asked them to
send me an interpreter but they couldnt help me
(P1).
Another woman despite being sent a letter
saying that she was not a carrier, spoke of her
alarm as she could not read English and as with
the above quotation, confusion between trait
and disorder also occurred:
It aﬀects me because I dont understand what its
all about. There was nothing in Spanish either. The
doctor just said we are going to do this blood test.
I am confused till now because I dont know
whether I have got sickle cell condition or not (P3).
Discussion
Women expressed generally positive views about
being oﬀered SC&T screening in primary care at
a ﬁrst visit to conﬁrm pregnancy. To this extent
screening was acceptable to them. They did,
however, identify a strong need for more infor-
mation and greater discussion about the condi-
tions for which screening was being oﬀered as
well as the implications of testing. We now
explore this in more detail and show how
womens acceptability of screening and partici-
pation in informed decision making is best
understood in terms of broader social processes.
Regardless of ethnic origin and whether
women did or did not undergo screening,
womens acceptability of SC&T screening was
high; all recognised the beneﬁts of early screen-
ing. Women expressed a desire for a healthy
child and the need to know about the health
status of their unborn babies. Similar ﬁndings
were also expressed by GPs who oﬀered the test
to women.18 Nonetheless, positive comments
were largely related to womens expectation that
screening would conﬁrm a healthy pregnancy.
This is a major part of womens acceptability of
early screening: they did not think they would
have to make a decision about whether or not to
continue their pregnancies. This is reinforced by
GPs oﬀering the test, who were concerned about
raising the possibility of adverse outcomes at the
pregnancy conﬁrmation visit.18
Many studies have portrayed the idealised
view of the good mother in Western society,21–23
with women feeling responsible for bringing a
healthy baby into the world. Indeed in all
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cultures, women are encouraged to adhere to
and abstain from certain practices in order to
ensure the birth of a healthy child and fulﬁl their
moral obligation to their child as a good
mother.24 This experience is linked to their in-
ternalised sense of responsibility for their chil-
dren. Undergoing SC&T screening can be seen
as meeting this moral responsibility and this is
the basis of their participation. Woman in our
study believed that it was their responsibility, as
mothers, to follow the advice of health-care
professionals in order to bring a healthy child
into the world. The existence of screening
implies that it might be a good thing and that
the birth of a child with a SC or T disorder
might not be a good outcome. Rejecting
screening when they were considered at risk may
have been deemed irresponsible, particularly if
there was a negative outcome. They did not wish
to be judged as bad mothers.25
The women in the study indicated that they
trusted the doctors who were oﬀering SC&T
screening, felt safe and were grateful to be
oﬀered such an intervention. This further sup-
ported their sense of being a good mother.
Doctors were accepted as the source of
authoritative knowledge within the antenatal
context.26 It has been suggested that women may
hand control to health providers as a conse-
quence of their vulnerable state and the multiple
risks involved in pregnancy.27,28 This pattern of
behaviour was found in a study of Muslim
women25 and in a study of British womens
perceptions of midwifery care29 suggesting such
beliefs occur irrespective of ethnicity. This pas-
sivity reﬂects Porter and McIntyres30 thesis of
what is must be best: women believe that
available procedures provide the best options.
Interestingly, when mothers engaged in more
pro-active behaviour, such as wanting more
information about the test and its consequences,
they were also acting in accordance with their
expectations of what it is to be a good mother
by maximising the opportunities to have a
healthy child. This begins to explain the poten-
tial tension in their accounts in which they are
happy to trust and be directed by health-care
professionals as long as this does not undermine
the normative values associated with being a
good mother. Perceptions of previous deci-
sions, for example, can be re-evaluated if these
normative assumptions are later breached.
Women identiﬁed as carriers are known to
retrospectively question the process of screen-
ing.5 This complicates womens responses,10
particularly when many women might not have
known screening has taken place5 or at least fail
to understand the implications of screening.31
Acceptance of testing, therefore, is contingent
on but consistent with their ideas of being a
good mother, although the idea she is now car-
rying a faulty gene requires further social
negotiation.10
The non use of English by many patients and
the limited availability of interpreters are cur-
rently barriers to equitable, accessible and
appropriate service provision.32 In our study
women who did not speak English ﬂuently
found it especially diﬃcult to access and com-
municate their needs to GPs, often not being
aware that they had actually undergone SC&T
screening. This resulted in frustration and dis-
satisfaction, supporting Ahmed et al.s27 sug-
gestion that there is a gap between the
information women want and the information
they receive from health professionals. GPs also
expressed similar concerns about the lack of
interpreters for women whose ﬁrst language was
not English.18 This is one of the few ways in
which ethnic diﬀerences were expressed in the
study. Few other diﬀerences were found among
women of diﬀerent ethnic groups, although it
should be mentioned that white women, did not
consider themselves to be at risk of haemoglobin
disorders because of their ethnic origin and used
this to justify their refusal to have screening.
Health professionals did not contradict these
assumptions, raising the potential for inequita-
ble treatment of white women, which can also
explain the anger sometimes expressed by white
women, who are identiﬁed as a carrier.31 This
might create broad tensions when developing
screening programmes, where there is a strong
ethnic identiﬁcation with speciﬁc genetic dis-
orders, particular since evidence suggests that
the relationship might be a little less clear cut.11
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This raises the more general problem of health-
care professionals understanding of SC&T.
General practitioners, for example, are known to
struggle with basic ideas about transmission and
risk,32 a problem compounded by the cultural
complexity evoked when women make decisions
about screening (and the possibility of termina-
tion). Stereotypical views about faith and its
implications for ante-natal screening, for exam-
ple, can disadvantage women, with practitioners
speciﬁcally under-estimating the diversity of
peoples responses, which show individual sensi-
tivity to context, as people balance the need to
take a life, while preventing suﬀering.12,33
While many women in the current study felt
that they were given a choice by their GPs about
SC&T screening, the same women also revealed
how GPs presented the test in a positive light
and encouraged them to undergo it. This is
supported by GPs who report presenting the test
as routine rather than a choice to avoid complex
negotiations.18 This raises the issue of informed
choice and speciﬁcally womens deﬁnitions of
choice in health care. It suggests that womens
views of informed decision making may not
necessarily be realised in policy or practice.
Women did not have particularly high expecta-
tions of being given choice when making deci-
sions about screening, but were satisﬁed with
this. This is again consistent with their ideas of
being a good mother.
Pre-natal screening activities can lead some
women to conceptualise their pregnancies as
tentative.34 We had little evidence of this,
although this was probably because women had
little detailed prior knowledge of SC or T or the
potential consequences of screening. Most of the
women we spoke to also had a reassuring result,
which conﬁrmed their expectation that screening
would conﬁrm a healthy pregnancy. Moreover,
women rarely considered that their child might
have another genetic condition, or more general
disability, after receiving conﬁrmation that they
were not a carrier of SC&T trait. This suggests
choice can be further compromised as speciﬁc
testing can give the illusion of more general
reassurance. As we have seen, the screening
process can also breach the liminal state between
health and illness; adding further complexities to
the process.
Realising informed choice is a longstanding
problem.9 Our ﬁndings suggest a need for those
working in primary care to engage more with the
context in which women make choices and in
particular how women make sense of their
pregnancy. This is a social and emotional
response, which requires careful negotiation,
particularly when practitioners attempt to facil-
itate informed choice.34 Women and doctors are
sometimes reluctant to acknowledge this, as
both parties seek speedy and straightforward
resolutions to what are complex decisions.
Women seem happy to accept the relatively
directive nature of informed choice during ante-
natal care, as long as it provides news of a
healthy baby, while conﬁrming they are mor-
ally worthy mothers. Testing often becomes
reduced to a bio-technical act rather than an
enactment of a socially negotiated practice.35
Practitioners, while respecting autonomy also
need to acknowledge that women will defer to
medical authority. The task of the health-care
professional, therefore, is to engage with what
women understand is happening to them, within
the context of current health-care practices. This
is how meaningful choices emerge and auton-
omy should be seen as an ideal governing action
rather than an empirical criterion.36 Health
professionals have an ethical and conscientious
responsibility not to simply oﬀer relevant
information, under the pretext of informed
choice, but also acknowledge the authoritative
role they place in inculcating patients into
normative health-care practices.37 This is the
basis of a reﬂexive relationship, in which prac-
titioners question how they imagine informed
choice in a way that enables them to respond to
the needs of women without recourse to gener-
alised notions of expectations, while working
with womens own deﬁnitions of who they are.37
Conclusion
Overall, women had positive attitudes towards
being oﬀered SC&T screening in primary care at
their ﬁrst visits to conﬁrm their pregnancies. To
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this extent it was acceptable for them. They did,
however, identify a strong need for more infor-
mation and discussion about the conditions for
which screening was being oﬀered and the
implications of the test. Discrepancies appeared
between how women exercised choice and the
ideals expressed in policy. Their sense of being a
good mother and trust of health-care profes-
sionals is fundamental in understanding this and
informs their participation in the screening
process.
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